• Symbol: MNTR

Mentor Capital, Inc.
  • Home
  • About Us
    • About
    • Professional Support
    • Management Team
    • Board of Directors
  • Media
  • Portfolio & Investments
  • Investors Corner
    • Overview
    • News / Events
    • Company Information
    • Financial Information
    • Stock Data
    • SEC Filings
    • Corporate Governance
  • Press
  • FAQ
  • Contact
    • Contact Us
    • Funding Application
Mentor Capital, Inc.
  • Home
  • About Us
    • About
    • Professional Support
    • Management Team
    • Board of Directors
  • Media
  • Portfolio & Investments
  • Investors Corner
    • Overview
    • News / Events
    • Company Information
    • Financial Information
    • Stock Data
    • SEC Filings
    • Corporate Governance
  • Press
  • FAQ
  • Contact
    • Contact Us
    • Funding Application
(800) 574 – 6320
Request a call back
Write us
info@mentorcapital.com
5964 Campus Court
Plano, TX 75093
Home Investors Corner News / Events Press Releases

Press Releases

Investors Corner

Investors Corner

  • Overview
  • News / Events
    • Overview
    • Press Releases
    • IR Calendar
    • Email Alerts
  • Company Info
    • Overview
    • Profile
    • Presentations
    • Media
    • Management Team
    • Contacts
    • FAQ
  • Financial Info
    • Overview
    • Balance Sheet
    • Income Statement
    • Cash Flow
    • Financial Results
  • Stock Data
    • Overview
    • Quote
    • Charts
    • Historical Data
  • SEC Filings
    • Overview
    • All SEC Filings
    • Annual Reports
    • Quarterly Reports
    • Section 16 Filings
    • Other Disclosures
  • Governance
    • Overview
    • Board of Directors
    • Board Committees
    • Governance Documents
  • Investor Tools
    • Email Alerts
    • Tear Sheet
    • Contacts
    • RSS News Feed
  • News / Events

  • Overview
  • Press Releases
  • IR Calendar
  • Email Alerts
  • Mentor Capital Initiates COVID-19 Related Investments

    • Dec 21, 2020
    gfarmalabs

    Pfizer, Moderna, BioNTech and AstraZeneca Lead Off in Mentor’s New Medical Investments Portfolio PLANO, Texas--(BUSINESS WIRE)-- Mentor Capital, Inc. (OTCQB: MNTR) announced that it has added a business segment that focuses on the vaccine and associated medical companies involved in the fight against SARS-CoV-2. The initial public companies in the small internal portfolio are Pfizer,…

    read more
  • Mentor Capital Reports 3rd Quarter 2020 10-Q

    • Nov 16, 2020
    gfarmalabs

    Trailing Annual Revenues Are Double Market Capitalization for Texas M&A Company PLANO, Texas--(BUSINESS WIRE)-- Mentor Capital, Inc. (OTCQB: MNTR) announced that it had filed its quarterly 10-Q filing for the third quarter ended September 30, 2020, with the Securities and Exchange Commission. The Company reports that for the quarter ended September 30, 2020 Mentor had revenues of…

    read more
  • Mentor Capital Reports 12.5% Growth in 2nd Quarter 2020 10-Q

    • Aug 13, 2020
    gfarmalabs

    Annualized Current Revenues are 240% of Market Capitalization for M&A Company SAN DIEGO--(BUSINESS WIRE)-- Mentor Capital, Inc. (OTCQB: MNTR) announced a 12.5% year-over-year revenue growth for the second three months of the year in its quarterly 10-Q filing for the second quarter ended June 30, 2020, filed with the Securities and Exchange Commission. The Company reports that for the…

    read more
  • Mentor Capital Reports 1st Quarter 2020 10-Q

    • May 15, 2020
    gfarmalabs

    Trailing Revenues Continue to Exceed Market Capitalization for M&A Company SAN DIEGO--(BUSINESS WIRE)-- Mentor Capital, Inc. (OTCQB: MNTR) announced that it had filed its quarterly Form 10-Q filing for the first quarter ended March 31, 2020, with the Securities and Exchange Commission coincident with a move to the OTCQB. The Company reports that for the quarter ended March 31, 2020,…

    read more
  • Mentor Capital Reports 3rd Quarter 2019 10-Q

    • Nov 12, 2019
    gfarmalabs

    Trailing Revenues Exceed Market Capitalization for M&A Company SAN DIEGO--(BUSINESS WIRE)-- Mentor Capital, Inc. (OTCQX: MNTR) announced that it had filed its quarterly 10-Q filing for the third quarter ended September 30, 2019, with the Securities and Exchange Commission. The Company reports that for the quarter ended September 30, 2019 Mentor had revenues of $1,071,337 and gross…

    read more
  • Mentor Capital Reports 2nd Quarter 2019 10-Q

    • Aug 14, 2019
    gfarmalabs

    Quarterly 10-Q Filing for Marijuana and Cannabis M&A Company SAN DIEGO--(BUSINESS WIRE)-- Mentor Capital, Inc. (OTCQX: MNTR) announced that it had filed its quarterly 10-Q filing for the second quarter ended June 30, 2019 with the Securities and Exchange Commission. The Company reports that for the quarter ended June 30, 2019 Mentor had revenues of $1,029,749 and gross profit of…

    read more
  • Mentor Capital Reports 1st Quarter 2019 10-Q

    • May 16, 2019
    gfarmalabs

    SAN DIEGO, CA / ACCESSWIRE / May 16, 2019 / Mentor Capital, Inc. (OTCQX: MNTR) announced that it had filed its quarterly 10-Q filing for the first quarter ended March 31, 2019, with the Securities and Exchange Commission. The Company reports that for the quarter ended March 31, 2019, Mentor had revenues of $1,075,995 and gross profit of $370,374 with a resulting net loss attributable to Mentor…

    read more
  • Mentor Capital Reports 66% 2018 Revenue Increase in 10-K

    • Mar 29, 2019
    gfarmalabs

    Annual 10-K Filing for Marijuana and Cannabis M&A Company SAN DIEGO, CA / ACCESSWIRE / March 29, 2019 / Mentor Capital, Inc. (OTCQX: MNTR) announced that it had filed its annual 10-K filing for the year December 31, 2018, with the Securities and Exchange Commission. The Company reports that for the year ended December 31, 2018 Mentor had revenues of $5,281,533 and gross profit of $1,582,599…

    read more
  • Mentor Capital Turns Profitable on 26% Year on Year Revenue Gains

    • Nov 14, 2018
    gfarmalabs

    Third Quarter 10-Q Filing for Marijuana and Cannabis M&A Company SAN DIEGO, CA / ACCESSWIRE / November 14, 2018 / Mentor Capital, Inc. (OTCQX: MNTR) announced that it had filed its quarterly 10-Q filing for the third quarter ended September 30, 2018, with the Securities and Exchange Commission. For the quarter ended September 30, 2018, Mentor had revenues of $1,031,622 and gross profit…

    read more
  • Mentor Capital to Present on the Cannabis Market Thursday, October 4, 2018 at 9:30 (PDT) at the OTCQX Virtual Investor Conference

    • Oct 4, 2018
    gfarmalabs

    SAN DIEGO, Oct. 04, 2018 (GLOBE NEWSWIRE) -- Mentor Capital, Inc. (OTCQX: MNTR) announced that it has been invited to present and answer investor questions at the OTCQX® Virtual Investor Conference on October 4, 2018, featuring US-based issuers traded on the OTCQX Best Market. Mentor’s CEO, Chet Billingsley, will be discussing the magnitude and potential of the American cannabis market,…

    read more
RSS
    • 1
    • 2
    • 3
    • 4
    • 5
    • 6
    • 7
    • 8

    Navigation

    • Home
    • Contact
    • Safe Harbor Statement
    • Privacy Policy
    • Disclaimer
    • Sitemap

    Mentor Capital, Inc

    Mentor Capital, Inc. (MNTR) is a publicly traded operating company that provides owners and pre-IPO companies with access to liquidity and funding from both public sources and the divestiture of legacy assets.

    Subscribe

    Recent News

    • Mentor Capital Posts 28% Annual Revenue Increase Mar 29, 2023
    • Mentor Capital Harvests Half of Market Value in Cash from Side Investments and Reports 30% Q3 Sales Growth Nov 21, 2022
    • Mentor Capital Posts 1 Cent Net Profit on a 4 Cent Share Price in 10-Q Aug 15, 2022
    Copyright © 2023 Mentor Capital, Inc. All rights reserved.